Y+L amino acid transporter 1 is a protein that in humans is encoded by the SLC7A7 gene.[5][6]
Interactions
SLC7A7 has been shown to interact with SLC3A2.[7]
See also
References
Further reading
- Lauteala T, Sistonen P, Savontaus ML, et al. (1997). "Lysinuric protein intolerance (LPI) gene maps to the long arm of chromosome 14". Am. J. Hum. Genet. 60 (6): 1479–86. doi:10.1086/515457. PMC 1716131. PMID 9199570.
- Pfeiffer R, Rossier G, Spindler B, et al. (1999). "Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family". EMBO J. 18 (1): 49–57. doi:10.1093/emboj/18.1.49. PMC 1171101. PMID 9878049.
- Borsani G, Bassi MT, Sperandeo MP, et al. (1999). "SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance". Nat. Genet. 21 (3): 297–301. doi:10.1038/6815. PMID 10080183. S2CID 38960307.
- Sperandeo MP, Bassi MT, Riboni M, et al. (2000). "Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance". Am. J. Hum. Genet. 66 (1): 92–9. doi:10.1086/302700. PMC 1288352. PMID 10631139.
- Mykkänen J, Torrents D, Pineda M, et al. (2000). "Functional analysis of novel mutations in y(+)LAT-1 amino acid transporter gene causing lysinuric protein intolerance (LPI)". Hum. Mol. Genet. 9 (3): 431–8. doi:10.1093/hmg/9.3.431. PMID 10655553.
- Noguchi A, Shoji Y, Koizumi A, et al. (2000). "SLC7A7 genomic structure and novel variants in three Japanese lysinuric protein intolerance families". Hum. Mutat. 15 (4): 367–72. doi:10.1002/(SICI)1098-1004(200004)15:4<367::AID-HUMU9>3.0.CO;2-C. PMID 10737982. S2CID 29088822.
- Shoji Y, Noguchi A, Shoji Y, et al. (2003). "Five novel SLC7A7 variants and y+L gene-expression pattern in cultured lymphoblasts from Japanese patients with lysinuric protein intolerance". Hum. Mutat. 20 (5): 375–81. doi:10.1002/humu.10140. PMID 12402335. S2CID 23833183.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS...9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Mykkänen J, Toivonen M, Kleemola M, et al. (2003). "Promoter analysis of the human SLC7A7 gene encoding y+L amino acid transporter-1 (y+LAT-1)". Biochem. Biophys. Res. Commun. 301 (4): 855–61. doi:10.1016/S0006-291X(03)00054-8. PMID 12589791.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Sperandeo MP, Paladino S, Maiuri L, et al. (2005). "A y(+)LAT-1 mutant protein interferes with y(+)LAT-2 activity: implications for the molecular pathogenesis of lysinuric protein intolerance". Eur. J. Hum. Genet. 13 (5): 628–34. doi:10.1038/sj.ejhg.5201376. PMID 15756301.
- Sperandeo MP, Annunziata P, Ammendola V, et al. (2006). "Lysinuric protein intolerance: identification and functional analysis of mutations of the SLC7A7 gene". Hum. Mutat. 25 (4): 410. doi:10.1002/humu.9323. PMID 15776427.
- Puomila K; Simell O; Huoponen K; Mykkänen J (2007). "Two alternative promoters regulate the expression of lysinuric protein intolerance gene SLC7A7". Mol. Genet. Metab. 90 (3): 298–306. doi:10.1016/j.ymgme.2006.11.007. PMID 17196863.
- Cimbalistiene L; Lehnert W; Huoponen K; Kucinskas V (2007). "First reported case of lysinuric protein intolerance (LPI) in Lithuania, confirmed biochemically and by DNA analysis". J. Appl. Genet. 48 (3): 277–80. doi:10.1007/BF03195224. PMID 17666782. S2CID 24454281.
|
---|
By group |
---|
SLC1–10 |
---|
(1): | |
---|
(2): | |
---|
(3): | |
---|
(4): | |
---|
(5): | |
---|
(6): | |
---|
(7): | |
---|
(8): | |
---|
(9): | |
---|
(10): | |
---|
|
| SLC11–20 |
---|
(11): |
- proton coupled metal ion transporter
|
---|
(12): | |
---|
(13): |
- human Na+-sulfate/carboxylate cotransporter
|
---|
(14): | |
---|
(15): |
- proton oligopeptide cotransporter
|
---|
(16): |
- monocarboxylate transporter
|
---|
(17): | |
---|
(18): | |
---|
(19): | |
---|
(20): | |
---|
|
| SLC21–30 |
---|
(21): | |
---|
(22): | |
---|
(23): |
- Na+-dependent ascorbic acid transporter
|
---|
(24): | |
---|
(25): | |
---|
(26): |
- multifunctional anion exchanger
|
---|
(27): | |
---|
(28): |
- Na+-coupled nucleoside transport (SLC28A1
|
---|
(29): |
- facilitative nucleoside transporter
|
---|
(30): | |
---|
|
| SLC31–40 |
---|
(31): | |
---|
(32): | |
---|
(33): | |
---|
(34): |
- type II Na+-phosphate cotransporter
|
---|
(35): |
- nucleoside-sugar transporter
-
-
-
-
- SLC35E1
- SLC35E2
- SLC35E3
- SLC35E4
|
---|
(36): | |
---|
(37): |
- sugar-phosphate/phosphate exchanger
|
---|
(38): |
- System A & N, sodium-coupled neutral amino-acid transporter
|
---|
(39): | |
---|
(40): |
- basolateral iron transporter
|
---|
|
| SLC41–48 |
---|
(41): | |
---|
(42): | |
---|
(43): |
- Na+-independent, system-L like amino-acid transporter
|
---|
(44): | |
---|
(45): |
- Putative sugar transporter
|
---|
(46): | |
---|
(47): | |
---|
(48): | |
---|
|
| |
|
|
|
see also solute carrier disorders |
External links